0001209191-20-065233.txt : 20201228 0001209191-20-065233.hdr.sgml : 20201228 20201228174339 ACCESSION NUMBER: 0001209191-20-065233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201222 FILED AS OF DATE: 20201228 DATE AS OF CHANGE: 20201228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Menard Chrystal CENTRAL INDEX KEY: 0001564252 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 201419382 MAIL ADDRESS: STREET 1: C/O CERUS CORPORATION STREET 2: 2550 STANWELL DRIVE CITY: CONCORD STATE: CA ZIP: 94520 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-22 0 0001020214 CERUS CORP CERS 0001564252 Menard Chrystal C/O CERUS CORPORATION 1220 CONCORD AVE SUITE 600 CONCORD CA 94520 0 1 0 0 Chief Legal Officer Common Stock 2020-12-22 4 M 0 85416 4.33 A 134001 D Common Stock 2020-12-22 4 S 0 85416 8.00 D 48585 D Common Stock 2020-12-22 4 M 0 57395 4.32 A 105980 D Common Stock 2020-12-22 4 S 0 57395 8.00 D 48585 D Common Stock 2020-12-22 4 M 0 68516 4.46 A 117101 D Common Stock 2020-12-22 4 S 0 68516 8.00 D 48585 D Option (Right to Buy) 4.33 2020-12-22 4 M 0 85416 D 2027-02-28 Common Stock 85416 10417 D Option (Right to Buy) 4.32 2020-12-22 4 M 0 57395 D 2028-02-28 Common Stock 57395 33646 D Option (Right to Buy) 4.46 2020-12-22 4 M 0 68516 D 2025-03-01 Common Stock 68516 0 D This transaction was executed pursuant to a 10b5-1 plan. This transaction was executed pursuant to a 10b5-1 plan. The reported sale price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter. Not applicable. Chrystal Menard 2020-12-28